Mitochondria-mediated apoptosis operating irrespective of multidrug resistance in breast cancer cells by the anticancer agent prodigiosin.
about
Anticancer and immunosuppressive properties of bacterial prodigininesGlibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231.Molecular interactions of prodiginines with the BH3 domain of anti-apoptotic Bcl-2 family membersStaphylococcal entorotoxin B anchored exosome induces apoptosis in negative esterogen receptor breast cancer cells.Enhanced production of prodigiosin by Serratia marcescens MO-1 using ram horn peptone.Targeting survivin with prodigiosin isolated from cell wall of Serratia marcescens induces apoptosis in hepatocellular carcinoma cells.An In silico Chimeric Vaccine Targeting Breast Cancer Containing Inherent AdjuvantDifferential control of growth, apoptotic activity, and gene expression in human breast cancer cells by extracts derived from medicinal herbs Zingiber officinale.Apoptotic effect of tolfenamic acid on MDA-MB-231 breast cancer cells and xenograft tumors.Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells.Prodigiosin and its potential applicationsPromotion of breast cancer cells MDA-MB-231 invasion by di(2-ethylhexyl)phthalate through matrix metalloproteinase-2/-9 overexpression.Characterization and enhanced production of prodigiosin from the spoiled coconut.A 2-substituted prodiginine, 2-(p-hydroxybenzyl)prodigiosin, from Pseudoalteromonas rubraCharacterization of bacterium isolated from the sediment at coastal area of Omura Bay in Japan and several biological activities of pigment produced by this isolate.Indole-based perenosins as highly potent HCl transporters and potential anti-cancer agentsThe anticancer agent prodigiosin is not a multidrug resistance protein substrate.Mitochondrial dysfunction in Trypanosoma cruzi: the role of Serratia marcescens prodigiosin in the alternative treatment of Chagas diseaseRegulation of p53 and survivin by prodigiosin compound derived from Serratia marcescens contribute to caspase-3-dependent apoptosis in acute lymphoblastic leukemia cells.Apoptosis of epithelial cells and macrophages due to nonpigmented Serratia marcescens strains.
P2860
Q28258853-8A459FB5-0C8C-49EE-8276-697F6041D85FQ34545864-11C0CA13-F5F8-4C4B-9360-14EAC3DE0ED3Q34608671-CE23DA4E-94E2-4D40-A69C-EB41E119C56EQ35084666-46876849-54AE-4248-A10F-DC41B78785F8Q35866555-40A8D524-97B3-4D0F-AC86-3A628D3D9584Q36059385-E812CF74-0C7E-44B2-B432-8F9EE320F842Q36088818-32C7A58D-47E4-42DA-8624-E9FFD161A676Q36206691-6EA4FFB9-0BDE-493F-95BA-93A58BE00743Q36993540-9494E839-0685-4A86-B816-C31D076DCAC4Q37469714-8A31EBF3-51DE-42F4-9966-C152C3FDE4A4Q38582173-78CDD794-A9B6-4D6D-B045-1B03BF07F988Q38796179-4CAD72D4-EB07-4DDC-B642-3C058CCA8055Q39688492-B2585347-1060-451C-A25F-CF55BD752BF5Q39929182-B142B392-194D-4CA0-AA1E-5B15930DCABAQ40419731-A167F611-3E6F-4868-8286-69AAB65DDC81Q41516082-A9C946FC-3DB4-478D-953C-B771ACE1B4F4Q41539054-5393BB94-F1D7-4EE3-9A3E-098F39F2AD44Q42765317-C5F2DB9D-5B95-46AB-BE2A-7561CAEDC4DFQ50905546-53227815-7BEA-4247-8D2D-0E5EBE9FDB48Q55480806-383B411F-2410-47B2-B0D3-AA6320ED3F67
P2860
Mitochondria-mediated apoptosis operating irrespective of multidrug resistance in breast cancer cells by the anticancer agent prodigiosin.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Mitochondria-mediated apoptosi ...... anticancer agent prodigiosin.
@en
Mitochondria-mediated apoptosi ...... anticancer agent prodigiosin.
@nl
type
label
Mitochondria-mediated apoptosi ...... anticancer agent prodigiosin.
@en
Mitochondria-mediated apoptosi ...... anticancer agent prodigiosin.
@nl
prefLabel
Mitochondria-mediated apoptosi ...... anticancer agent prodigiosin.
@en
Mitochondria-mediated apoptosi ...... anticancer agent prodigiosin.
@nl
P50
P1476
Mitochondria-mediated apoptosi ...... anticancer agent prodigiosin.
@en
P2093
Esther Llagostera
George L Scheffer
P304
P356
10.1016/J.BCP.2004.05.056
P407
P577
2004-10-01T00:00:00Z